Last update:

Oncology & Cancer news

Oncology & Cancer

New radiotherapy technique aims to protect the heart during lung cancer treatment

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to evaluate the impact of treatment modifications in radiotherapy. The paper also appears in Radiotherapy ...

Oncology & Cancer

Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results

Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after menopause. The majority of women are diagnosed at an early stage, when treatment outcomes are generally ...

Oncology & Cancer

Origins of common lung cancer that affects smokers discovered

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL, the Wellcome Sanger Institute and the ...

Oncology & Cancer

More men with prostate cancer are avoiding unnecessary surgery

Prostate cancer is a leading cause of cancer-related death among men in the United States. Despite this, widespread adoption of prostate cancer screening has been controversial. Many primary care doctors worry that screening ...

Oncology & Cancer

New research guides treatment regimen for aggressive blood cancer

Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found that patients with these ...

Oncology & Cancer

PBAF chromatin may explain melanoma spread to the brain

Scientists at the Icahn School of Medicine at Mount Sinai have discovered a possible reason why some cases of melanoma—a dangerous form of skin cancer—spread to the brain. Their study, published in Molecular Cell, highlights ...

Oncology & Cancer

Uncovering inequalities in breast cancer immunotherapy access

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases. Black women are twice as likely as white women to be diagnosed with TNBC and 28% more likely to die ...

Oncology & Cancer

Biomarker panel offers hope for early pancreatic cancer detection

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. In Ireland, there are approximately 900 cases of PC ...

Oncology & Cancer

Inherited cancer risk: Large-scale screen homes in on 380 variants

Thousands of single changes in the nucleotides that make up the human genome have been associated with an increased risk of developing cancer. But until now, it's not been clear which are directly responsible for the uncontrolled ...

Oncology & Cancer

Light-activated dyes show promise in targeting cancer cells

Melanoma is one of the most aggressive skin cancers, with more than 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly. However, early detection and advanced treatments ...

Medications

Scientists propose CDK2 enzyme as new target for cancer therapy

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs—including a class of targeted treatments known as CDK4/6 ...

Oncology & Cancer

Study sets benchmark for treatment of advanced cervical cancer

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for evaluating ...

Oncology & Cancer

A newly discovered biomarker can predict cancer aggressiveness

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma ...